Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and Opportunities for Pancreatic Cancer Immunotherapy
Adham S. Bear, Robert H. Vonderheide, Mark H. O’Hara
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 788-802
Open Access | Times Cited: 443

Showing 1-25 of 443 citing articles:

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 600
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 299
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 242
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 176
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming
Sen Yang, Qiaofei Liu, Quan Liao
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 153
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz, Carolina Hirsch, Tanner C. Dalton, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 720-737.e5
Open Access | Times Cited: 138
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
Daniel Cui Zhou, Reyka G. Jayasinghe, Siqi Chen, et al.
Nature Genetics (2022) Vol. 54, Iss. 9, pp. 1390-1405
Open Access | Times Cited: 136
LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Yihao Liu, Minmin Shi, Xingfeng He, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 117
Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Xin Guan, Liping Sun, Yuting Shen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 111
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
Gregor Werba, Daniel Weissinger, Emily Kawaler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes
Alessandro Di Federico, Mirta Mosca, Rachele Pagani, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2429-2429
Open Access | Times Cited: 75
Artificial intelligence in pancreatic cancer
Bowen Huang, Haoran Huang, Shuting Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 6931-6954
Open Access | Times Cited: 70
Immunologic tumor microenvironment modulators for turning cold tumors hot
Gholamreza Khosravi, Samaneh Mostafavi, Sanaz Bastan, et al.
Cancer Communications (2024) Vol. 44, Iss. 5, pp. 521-553
Open Access | Times Cited: 61
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
Loretah Chibaya, Katherine Murphy, Kelly D. DeMarco, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 872-892
Open Access | Times Cited: 58
Platinum Prodrug Nanoparticles with COX‐2 Inhibition Amplify Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer
Bingzheng Yu, Yushu Wang, Tiejun Bing, et al.
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 54
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, et al.
Nature Cancer (2023) Vol. 4, Iss. 4, pp. 454-467
Open Access | Times Cited: 50
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
The effect of physical exercise on anticancer immunity
Carmen Fiuza‐Luces, Pedro L. Valenzuela, Beatriz G. Gálvez, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 282-293
Open Access | Times Cited: 46
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer
Ugo Boggi, Emanuele F. Kauffmann, Niccolò Napoli, et al.
Annals of Surgery (2024)
Open Access | Times Cited: 20
Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors
Keshuang Zheng, Yongpu Feng, Lie Li, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 761-787
Open Access | Times Cited: 18
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer
Caili Xu, Xiting Huang, Qinchao Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117550-117550
Open Access | Times Cited: 17
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
Yalan Deng, Xianghou Xia, Yang Zhao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top